Range
98.83 - 103
Vol / Avg.
1.5M/1.1M
Div / Yield
-
52 Wk
86.02 - 136.26
Mkt Cap
9.5B
Payout Ratio
-
Open
98.83
P/E
24.52
EPS
3.72
Shares
94.5M
Outstanding
94.5M
Total Float
93.3M
Benzinga - May 6, 2021, 8:48AM
Benzinga - May 6, 2021, 8:14AM
Benzinga - May 6, 2021, 7:22AM
Benzinga - May 5, 2021, 4:32PM
Benzinga - Apr 26, 2021, 4:02PM
Benzinga - Apr 26, 2021, 10:12AM
Benzinga - Apr 19, 2021, 10:51AM
Benzinga - Apr 12, 2021, 8:17AM
Benzinga - Apr 8, 2021, 4:01PM
Benzinga - Apr 8, 2021, 3:59PM
Benzinga - Mar 19, 2021, 1:36PM
Benzinga - Mar 2, 2021, 11:22AM
Benzinga - Mar 2, 2021, 7:35AM
Benzinga - Feb 5, 2021, 1:21PM
Benzinga - Feb 5, 2021, 11:24AM
Benzinga - Feb 4, 2021, 4:12PM
Benzinga - Feb 4, 2021, 4:12PM
Benzinga - Feb 2, 2021, 6:06AM
Benzinga - Jan 8, 2021, 7:33AM
Benzinga - Dec 16, 2020, 12:58PM
load more
Sector: Health Care.Industry: Biotechnology
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-02
REV
Q1 2021Est.ActualSurprise
EPS0.5100.490 -0.0200
REV250.630M236.600M-14.030M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
NBIXNeurocrine Biosciences2.13%9.5B

Neurocrine Biosciences Frequently Asked Questions

Q

How do I buy Neurocrine Biosciences (NBIX) stock?

A

You can purchase shares of Neurocrine Biosciences (NASDAQ: NBIX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Neurocrine Biosciences's (NBIX) competitors?

A

Other companies in Neurocrine Biosciences’s space includes: Exact Sciences (NASDAQ:EXAS), Amgen (NASDAQ:AMGN), BioNTech (NASDAQ:BNTX), Natera (NASDAQ:NTRA) and Arrowhead Pharmaceuticals (NASDAQ:ARWR).

Q

What is the target price for Neurocrine Biosciences (NBIX) stock?

A

The latest price target for Neurocrine Biosciences (NASDAQ: NBIX) was reported by Morgan Stanley on May 6, 2021. The analyst firm set a price target for 116.00 expecting NBIX to rise to within 12 months (a possible 15.40% upside). 25 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Neurocrine Biosciences (NBIX)?

A

The stock price for Neurocrine Biosciences (NASDAQ: NBIX) is $100.52 last updated Fri Jun 18 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Neurocrine Biosciences (NBIX) pay a dividend?

A

There are no upcoming dividends for Neurocrine Biosciences.

Q

When is Neurocrine Biosciences (NASDAQ:NBIX) reporting earnings?

A
Neurocrine Biosciences’s Q2 earnings are confirmed for after-market on August 2, 2021.
Q

Is Neurocrine Biosciences (NBIX) going to split?

A

There is no upcoming split for Neurocrine Biosciences.

Q

What sector and industry does Neurocrine Biosciences (NBIX) operate in?

A

Neurocrine Biosciences is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.